Deon Wolpowitz is a Dermatology physician affiliated with Boston University. OpenAlex indexes 26 publications with 1,182 citations (h-index 11); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
10 Laurel Ave Ste 300
Wellesley Hills, MA 02481
Telephone
781-235-8155Provider last certified this registry record 30 Sept 2024.
Clinical trials
- Neurobiology of the Scalp in Seborrheic Dermatitis
Sponsor: Boston University
- Impact of Vorinostat on Pruritus Signaling Pathways - Merck Study
Sponsor: Boston University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
24 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year202510 payments
- Incyte CorporationProgram year20254 payments
- Galderma Laboratories, L.P.Program year20255 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
36%Azole Antifungal28.6%Ketoconazole100%Part D≥63 patientsTetracycline-class Drug5%Doxycycline Monohydrate100%Part D<11 patients+ 1 more class in this area
Sensory organs
22.6%Corticosteroid22.6%Clobetasol Propionate63%Betamethasone Dipropionate23%Betamethasone Diprop Augmented14%Part D≥55 patientsDermatology
14.1%Corticosteroid10.8%Triamcinolone acetonide60%Triamcinolone Acetonide40%Part D + Part B≥18 patientsInterleukin-4 Receptor alpha Antagonist3.3%Dupixent Pen100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Loss of Papillary Dermal Calcitonin Gene Related Peptide-Expressing Neurons Significantly Correlates with Uremic Pruritus
Journal of Investigative Dermatology
2016 - Breast nodularity and ulceration: diffuse dermal angiomatosis a corticosteroid responsive disease
Dermatology Online Journal
2016
Similar KOLs
Other experts from the same institution or the same specialty.
Michael Holick, MD
Boston University
Gene Kwan, MD
Boston University
Joseph Antin, MD
Boston University
George O'Connor, MD
Boston University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”